AEMD stock: buy or sell?
February 25th, 2020
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide.
Should I buy AEMD stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Aethlon Medical stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Aethlon Medical stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for AEMD stock for the last 30 days.
AEMD stock analysis
Aethlon Medical shares plummed -17.55% to $2.02 today.
Aethlon Medical closed today at $2.02 and plummed a hair-raising -17.55%. In the last 22 days when AEMD stock price broke down the SMA200d line, it slid $-2.32 per share (-53.46%). AEMD shows a short term strength with several rising tops and rising bottoms. In the very short term, on Feb 4th it marked a new bottom at $2.50 that should act a support if Aethlon Medical starts a trading flat base in the range of $2.50 - $4.34 Trading the long side, we should wait to a new breakout over $4.34 to find the next buy point.
Aethlon Medical shares plummed -21.71% this week, ending at $2.02. Late January AEMD climbed an astounding 44.70% in just one week.
Having descending tops is not good news for the long side. Although it's only a warning signal, traders should be on alert during next weeks to identify possible new signals. It's important AEMD stock price keeps the level, and maybe bounce up from there forming a double bottom pattern.
AEMD stock price history
AEMD stock went public on February 11th, 2002 with a price of $65.001. Since then, AEMD stock declined a -96.90%, with a yearly average of -5.40%.
1: Adjusted price after possible price splits or reverse-splits.
AEMD stock historical price chart
AEMD stock reached 52-week highs on March at $15.75, and all-time highs 2004-03-09 with a price of 212.5.
AEMD stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' AEMD stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price prediction for Aethlon Medical stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, Aethlon Medical reported its latest financial data, posting an extraordinary growth for the Earnings per Share (EPS) ratio. Experts expected $-0.07 per share, but Aethlon Medical posted $-0.11.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Aethlon Medical annual turnover plummed a dreadful -61.84% to $0.15 million dollars from $0.39 marked in 2017. Likewise, its income margin (compared to sales) plunged to -3,795.86%, that is $-5.68 million. To have an up to date picture of the financial situation of Aethlon Medical, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2018-Q4 that can be compared to 2018 fiscal year results. Annual Aethlon Medical TTM sales up to December 2018 were $0.22 and earnings were $-5.87 M USD. If we compare this TTM figures with the last reported annuality, we can review Aethlon Medical business evolution since March 2018: Annual revenues up to December, compared to lastest yearly report, boosted an amazing 50.00%. Regarding profit margin, Aethlon Medical skyrocketed 1,179.77% to -3,795.86%
|2013||$1.23 M||-||$-4.89 M-397.6%||-|
|2014||$1.62 M||31.71%||$-13.36 M-824.7%||173.21%|
|2015||$0.76 M||-52.94%||$-6.80 M-891.5%||-49.12%|
|2016||$0.89 M||16.28%||$-4.87 M-549.6%||-28.32%|
|2017||$0.39 M||-55.78%||$-7.28 M-1855.8%||49.34%|
|2018||$0.15 M||-61.84%||$-5.68 M-3795.9%||-21.94%|
|TTM||$0.22 M||50.00%||$-5.87 M-2616.1%||3.38%|
Quarterly financial resultsReported quarter income marked $-2.01 M with a profit margin of . Profit margin remained constant a 0.00% compared to previous quarter when profit margin was inf%. When comparing sales to same quarter last year, Aethlon Medical sales marked a spooky loss and collapsed a -100.00%. Looking back to recent quarterly results, Aethlon Medical posted 2 negative quarters in a row.
|2017-Q4||$0.07 M||-||$-1.22 M-1624.1%||-|
|2018-Q1||$0.07 M||0.00%||$-1.32 M-1762.9%||8.55%|
|2018-Q2||$0.15 M||100.00%||$-1.15 M-766.1%||-13.09%|
Aethlon Medical ownershipWhen you are planning to invest in a stock, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Aethlon Medical, 5.39% of all outstanding shares are owned by its staff.
In case of Aethlon Medical stock, 16.72% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AEMD stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Aethlon Medical:
|Market cap||$14.1 M|
|Total shares||7.0 M|
|Float shares||1.3 M|
|- Institutional holdings (%)||16.7%|
|- Insider holdings (%)||5.4%|
|Shares in short selling||0.0%|
|Tuesday, February 25th, 2020|
|Day range||$1.80 - $2.30|
|Average true range||$0.69|
|50d mov avg||$2.04|
|100d mov avg||$2.66|
|200d mov avg||$4.05|
Aethlon Medical performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We selected as the bechmarking frame for Aethlon Medical stock.